GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that management will present at the Piper Sandler 38th Annual Healthcare Conference in New York on Thursday, December 3, 2026 at 9:10 a.m. Eastern Time. Management will also host in-person investor meetings at the conference. A live webcast, as well.
Hyperfine, Inc. (HYPR) Q3 2026 Earnings Call Transcript
Hyperfine NASDAQ: HYPR reported record third-quarter revenue and gross margin, while narrowing its operating loss and reducing cash burn as sales of its portable brain MRI system increased across its U.S. and international markets.
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced third quarter 2026 financial results and provided a business update. “Q3 2026 marked the beginning of a new trajectory for Hyperfine. We delivered record revenue, gross profit, and gross margin, and for the first time quarterly revenue exceeded net.
Hyperfine (NASDAQ: HYPR - Get Free Report) and Sysmex (OTCMKTS:SSMXY - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, earnings, profitability and dividends. Profitability This table compares Hyperfine and Sysmex's net margins, return
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that management will host investor meetings at two healthcare conferences in November. UPCOMING CONFERENCES 2026 Jefferies Global Healthcare Conference in London - Wednesday, November 18 and Thursday, November 19, 2026. Management will be hosting in.
GUILFORD, Conn.--(BUSINESS WIRE)--CE mark and UKCA approvals support Swoop system Model 2 expansion as Hyperfine highlights portable MRI in brain health awareness efforts.
What happened Hyperfine, Inc. (NASDAQ: HYPR) said preliminary third-quarter revenue rose to about $6.0 million, while preliminary net cash burn fell to about $5.6 million. The company said revenue topped preliminary net cash burn for the first time. It also reaffirmed full-year 2026 revenue of about $20 million to $22 million and cash burn of
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that it will report financial results for the third quarter 2026 on Monday, November 9, 2026. Management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. A live audio webcast and an archive of the recordi.
GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced preliminary, unaudited revenue, net cash burn, and cash and cash equivalents for the third quarter ended September 30, 2026. “Our preliminary third-quarter results demonstrate that execution of our commercial strategy is driving meaningful growth. M.